Clinical trials
Completed Lung Diseases trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
22 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2011 | 1 |
| 2013 | 2 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 4 |
| 2018 | 3 |
| 2019 | 2 |
| 2020 | 3 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 22 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 3 |
| Guangzhou JOYO Pharma Co., Ltd | 2 |
| Peking University Third Hospital | 2 |
| Bayer | 1 |
| Bracco Diagnostics, Inc | 1 |
| Fudan University | 1 |
| Fujian Medical University Union Hospital | 1 |
| Hoffmann-La Roche | 1 |
| InSilico Medicine Hong Kong Limited | 1 |
| Jiangsu HengRui Medicine Co., Ltd. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lung Diseases | 22 |
| Respiratory Tract Diseases | 8 |
| Pulmonary Disease, Chronic Obstructive | 5 |
| Carcinoma, Non-Small-Cell Lung | 4 |
| Lung Neoplasms | 4 |
| Carcinoma, Bronchogenic | 3 |
| Idiopathic Pulmonary Fibrosis | 3 |
| Pulmonary Fibrosis | 3 |
| Thoracic Neoplasms | 3 |
| Asthma | 2 |
Trials
Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.